Acute localised otitis externa

If acute localised otitis externa presents as a boil and the patient is at low risk of methicillin-resistant Staphylococcus aureus (MRSA) infection (see Risk factors for infection with methicillin-resistant Staphylococcus aureus), empirical therapy targeting methicillin-susceptible S. aureus (MSSA) is appropriate. Use:

1dicloxacillin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly for 5 days. For dosage adjustment in adults with kidney impairment, see dicloxacillin dosage adjustment dicloxacillin dicloxacillin dicloxacillin

OR

1flucloxacillin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly for 5 days. For dosage adjustment in adults with kidney impairment, see flucloxacillin oral dosage adjustment. flucloxacillin flucloxacillin flucloxacillin

If acute localised otitis externa presents as painful erysipelas involving the pinna and external canal, which can be caused by Streptococcus pyogenes (group A streptococcus [GAS]), use:

phenoxymethylpenicillin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly for 5 days. phenoxymethylpenicillin phenoxymethylpenicillin phenoxymethylpenicillin

Cefalexin is often preferred to dicloxacillin or flucloxacillin in children because the liquid formulation is better tolerated. It can also be used for patients who have had a nonsevere (immediate or delayed) hypersensitivity reaction to penicillin1. Use:

1cefalexin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly for 5 days2. For dosage adjustment in adults with kidney impairment, see cefalexin dosage adjustment cefalexin cefalexin cefalexin

OR if adherence to a 6-hourly regimen is unlikely in a child

1cefalexin 20 mg/kg up to 750 mg orally, 8-hourly for 5 days3. cefalexin

For patients with acute localised otitis externa who are at increased risk of MRSA infection, or who have had a severe (immediate or delayed)4 hypersensitivity reaction to penicillin, use:

1trimethoprim+sulfamethoxazole 160+800 mg (child 1 month or older: 4+20 mg/kg up to 160+800 mg) orally, 12-hourly for 5 days. For dosage adjustment in adults with kidney impairment, see trimethoprim+sulfamethoxazole dosage adjustment trimethoprim + sulfamethoxazole trimethoprim+sulfamethoxazole trimethoprim+sulfamethoxazole

OR

2clindamycin 450 mg (child: 10 mg/kg up to 450 mg) orally, 8-hourly for 5 days5. clindamycin clindamycin clindamycin

Advise patients to return for review after 3 to 5 days if symptoms are not improving or earlier if symptoms worsen; systemic antibiotic therapy is usually curative, though surgical drainage may also be required.

1 Cefalexin may be used in patients who have had a nonsevere (immediate or delayed) reaction to amoxicillin or ampicillin. However, because cross-reactivity between these drugs is possible, consideration should be given to the extent of the reaction, patient acceptability, and the suitability of non–beta-lactam options.Return
2 For mild skin infection, administering the total daily dose of cefalexin in 2 12-hourly doses is also effective (ie cefalexin 1 g [child: 25 mg/kg up to 1 g] orally, 12-hourly).Return
3 Unpublished pharmacokinetic and pharmacodynamic modelling data for cefalexin show similar levels of target attainment with the 6- and 8-hourly regimens above. It is the consensus view of the Antibiotic Expert Group that either regimen can be used for children.Return
4 Severe immediate hypersensitivity reactions include anaphylaxis, compromised airway, airway angioedema, hypotension and collapse. Severe delayed hypersensitivity reactions include cutaneous adverse drug reactions (eg drug rash with eosinophilia and systemic symptoms [DRESS], Stevens–Johnson syndrome/toxic epidermal necrolysis [SJS/TEN], severe blistering or desquamative rash), and significant internal organ involvement (eg acute interstitial nephritis).Return
5 An oral liquid formulation of clindamycin is not commercially available; for formulation options for children or people with swallowing difficulties, see Don’t Rush to Crush, which is available for purchase from the Advanced Pharmacy Australia website or through a subscription to eMIMSplus.Return